US Patent Issued to The Regents of the University of California on Jan. 20 for "Cyanine-based telodendrimers and uses for treating cancer" (California Inventors)

ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,527,880, issued on Jan. 20, was assigned to The Regents of the University of California (Oakland, Calif.).

"Cyanine-based telodendrimers and uses for treating cancer" was invented by Kit S. Lam (Davis, Calif.) and Lu Zhang (Sacramento, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides a cyanine modified telodendrimer, nanoparticles thereof, and methods of using the nanoparticles to treat various diseases such as cancer."

The patent was filed on Aug. 30, 2019, under Application No. 17/272,021.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=P...